Jeffrey Leyton, University of Ottawa

Research

Antibody-Drug Conjugates Artificial Intelligence Deep Learning Machine Learning

Latest funding

Developing an AI-enhanced ADC design platform for industrial scalability
CIHR · 2026 · Nominated PI
$100,000

All 1 grants and awards

Developing an AI-enhanced ADC design platform for industrial scalability

Nominated PICIHR2026PJT PA: ICR - Lev. AI to Transform Can. Res. AI to Accelerate Cancer Research

Principal investigators: Leyton, Jeffrey V

Keywords: Antibody-Drug Conjugates; Artificial Intelligence; Deep Learning; Machine Learning

$100,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2026

Subject: Prospective PhD student: Antibody-Drug Conjugates Dear Professor Leyton, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on antibody-drug conjugates connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Developing an AI-enhanced ADC design platform for industrial scalability" (2026), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]